EVALUATING THE COST-EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES IN THE UK

被引：1
|
作者：
Ashley, D. [1 ]
Vega, G. [1 ]
Hunt, B. [2 ]
Valentine, W. J. [2 ]
机构：
[1] Novo Nordisk Ltd, Gatwick, England
[2] Ossian Hlth Econ & Commun, Basel, Switzerland
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2093
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB54
引用
收藏
页码：A606 / A606
页数：1
相关论文
共 50 条
  • [31] GLP-1 receptor agonists and basal insulin in type 2 diabetes
    Young, Laura A.
    Buse, John B.
    LANCET, 2014, 384 (9961): : 2180 - 2181
  • [32] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [33] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Kristina S. Boye
    Dara Stein
    Louis S. Matza
    Jessica Jordan
    Ren Yu
    Kirsi Norrbacka
    Syed Wasi Hassan
    Luis-Emilio García-Pérez
    Drugs in R&D, 2019, 19 : 213 - 225
  • [34] Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
    Boye, Kristina S.
    Stein, Dara
    Matza, Louis S.
    Jordan, Jessica
    Yu, Ren
    Norrbacka, Kirsi
    Hassan, Syed Wasi
    Garcia-Perez, Luis-Emilio
    DRUGS IN R&D, 2019, 19 (02) : 213 - 225
  • [35] Evaluating the Response to GLP-1 Agonists in Veterans with Type 2 Diabetes Mellitus
    Begley, Brett A.
    Desouza, Cyrus
    Shivaswamy, Vijay
    Samson, Kaeli
    Silverman, Emily
    DIABETES, 2021, 70
  • [36] A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes
    Ross, Stuart A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 125 - 135
  • [37] Are all GLP-1 agonists equal in the treatment of type 2 diabetes?
    Nauck, Michael A.
    Meier, Juris J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 181 (06) : R211 - R234
  • [38] Comparative Cost-Effectiveness Analysis of Bariatric Surgery and GLP-1 Receptor Agonists for the Management of Obesity
    Sanchez, Joseph
    Lundberg, Alexander
    Jones, Whitney
    Valukas, Catherine S.
    Lagu, Tara
    Teitelbaum, Ezra N.
    Stey, Anne
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S23 - S23
  • [39] GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
    Neumiller, Joshua J.
    Alicic, Radica Z.
    Tuttle, Katherine R.
    KIDNEY AND DIALYSIS, 2022, 2 (03): : 386 - 398
  • [40] GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes A Direct Comparison of Glycemic Control
    Seufert, J.
    DIABETOLOGIE UND STOFFWECHSEL, 2015, 10 (03) : 141 - 147
12345